CCHO hosts a successful webinar on Health Economics and Outcomes Research (HEOR)
On December 3rd, 2024, the Center for Clinical, Health Economics and Outcomes Research (CCHO), in collaboration with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) King Saud University (KSU), successfully hosted the fourth session of its ongoing webinar series dedicated to Health Economics and Outcomes Research (HEOR). This initiative, which aims to disseminate cutting-edge knowledge and foster collaboration among healthcare professionals, researchers and decision-makers, has gained significant momentum across the MENA region. The latest session brought together over 40 healthcare professionals, who actively participated in engaging discussions with key stakeholders. These discussions focused on critical advancements and the practical applications of HEOR in shaping healthcare.
As a seasoned expert in the field, the session commenced with Dr. Russell Becker, HEOR Lead at CCHO. Dr. Becker began by shedding light on the evolving and crucial role of HEOR within Health Technology Assessment (HTA). He provided an in-depth exploration of how HEOR has transitioned from being a supplementary component of healthcare research to becoming a cornerstone of evidence-based decision-making processes. His introduction emphasized that, as healthcare systems worldwide face growing demands and constrained budgets, the role of HEOR becomes more critical than ever in light of advancements in healthcare technologies and shifting priorities. Dr. Becker highlighted that HEOR sets a robust framework for evaluating cost-effectiveness and long-term value. This opening offered a strong foundation for the subsequent speakers to build upon.
Dr. Youmna Bassil, Senior HEOR Analyst at CCHO, followed with an overview of economic evaluation concepts. She detailed various types of costs, outcomes and health economic analyses, including Budget Impact Analysis (BIA), Cost of Illness (COI), Cost-Effectiveness Analysis (CEA), Cost-Minimization Analysis (CMA), Cost-Utility Analysis (CUA) and Cost-Benefit Analysis (CBA).
The session also featured Dr. Shiekha Alaujan, Associate Professor at the Clinical Pharmacy Department of King Saud University, who presented a systematic review of sources of outcomes and cost data used in economic evaluation research across the GCC. Her presentation highlighted best practices in the region, focusing on the methods used to identify, measure and value cost and outcomes data.
Moderated by Dr. Abdulrahman Alabkka, former ISPOR KSU Student Chapter President, the session concluded with an exciting interactive quiz led by Dr. Lea Ghajar, Business Development Associate at CCHO. The quiz not only tested participants’ knowledge but also added an element of suspense as the top five winners were announced.
What’s next?
CCHO is thrilled by the enthusiastic participation and extends its sincere gratitude to all attendees for their active engagement throughout the session. The next and final session in this series, focusing on Patient-Reported Outcomes (PROs), is scheduled for December 16th at 5:00 PM KSA time. Participants are encouraged not to miss this opportunity to conclude the program on a high note, with promises of plenty of surprises!
For more educational material in the field of Health Economics and Outcomes Research, explore our solutions.